Author: admin

Researchers identified 218 gut bacterial subspecies linked to colorectal cancer.Subspecies-level analysis offers clearer insights than traditional species-level studies.New tools may enable stool-based cancer tests that are faster and less invasive. Colorectal cancer is the second leading cause of cancer deaths worldwide, but it can be treatable when caught early. Unfortunately, many people delay diagnosis because colonoscopies, the main screening method, are often expensive and uncomfortable. Those barriers have created a need for better, less invasive ways to detect and understand the factors contributing to colorectal cancer, including the role of gut microbes.  While recent advances in technology have made it…

Read More

Registration is already open for the three-day event, which will take place Feb. 11 to 13, 2026 at The Convention Centre, Dublin, located in the heart of Ireland’s vibrant, popular and historic capital city.“Probiota gets bigger and better every year and is the meeting place to connect the business and science of microbiome modulation to improve human health,” said Stephen Daniells, PhD, editor-in-chief of NutraIngredients, editorial Consultant for Probiota and chair of the event. “The 2026 programme will feature some of the most exciting topics in the field, from strain optimization and next-gen biotics to the gut-brain axis. I recommend…

Read More

The earthy, umami flavor of mushrooms is a star in these recipes. From creamy soups and pasta to comforting casseroles, you’ll make the most of your mushrooms with these highly-rated main and side dishes. Our Spinach, Broccoli & Mushroom Quiche is the perfect addition to a brunch menu and our High-Protein Penne with Ground Turkey & Mushrooms is a quick dinner that you’ll want on repeat. Love any of these recipes? Join MyRecipes to save, search and organize your EatingWell recipes all in one place. It’s free! Spinach, Broccoli & Mushroom Quiche Photographer: Jen Causey, Food Stylist: Chelsea Zimmer, Prop…

Read More

Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic complexity, invasive growth, and immune resistance. A new therapeutic approach against GBM involves engineered dendritic cells that mimic the immune response to viral intruders. Jay Hartenbach President and Chief Operating Officer Diakonos OncologyIn this Innovation Spotlight, Jay Hartenbach, the president and chief operating officer of Diakonos Oncology, explains the company’s novel dendric cell cancer vaccine DOC1021, which has shown promising results in clinical trials. By “double-loading” patient-derived immune cells with patient-specific tumor mRNA and antigens, scientists have developed a…

Read More

Science minister Patrick Vallance has admitted that the price the NHS pays for medicines will have to rise in order to win back drug companies’ investment.Vallance also said that demands from US president Donald Trump for international drug price parity are a “big factor” in the dispute.When US pharmaceutical giant Merck halted construction on its £1bn London research centre earlier this month it became the latest …

Read More

Bayer Consumer Health spots untapped gut health market potential in Latin America due to prevalent digestive health issues and growing regional demand for solutions. The company launched its first probiotics in the region last year, Iberoflora Kids in Mexico, and recently added Iberoflora Adults to its offerings in the country as well. Nutrition Insight discusses the region’s gut health opportunities with Mónica Matienzo, marketing director of Mexico and Digestive Health category manager for Latin America, alongside Astrid Carolina Díaz, Bayer Consumer Health’s country medical lead in Consumer Health for Central America and the Caribbean and medical lead for Digestive Health…

Read More

New certificate series aims to empower students to accelerate the translation of aging science through the power of AI. Next month, Stanford University will launch a new program at the intersection of artificial intelligence and human longevity. The AI & Longevity Lab Certificate Series will explore how AI can be applied to healthspan science, aging biology, drug discovery, and predictive modeling, with the aim of giving participants both a foundation in longevity research and practical skills for building AI-powered tools. Unlike traditional lecture-only courses, the program emphasizes hands-on creation; students will not only study the science of aging but also…

Read More

A brain scan of a person with Huntington’s disease, which causes a loss of brain volume as neurons are killed off by the accumulation of a mutant protein.Credit: Zephyr/Science Photo LibraryA one-time gene therapy can markedly slow the progression of Huntington’s disease, potentially paving the way for the first ever treatment to alter the course of this rare, inherited brain disorder.In a small trial of 29 people who were in the early stages of Huntington’s-related decline, participants who received a high dose of the therapy directly into their brains saw the disease slow by 75% over three years, compared with…

Read More